Maryland State Retirement & Pension System’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
Other funds holding SUPN
AC
NAMI
SIMG
Maryland State Retirement & Pension System's SUPN Position: Q2 2026 in Review
Maryland State Retirement & Pension System increased its Supernus Pharmaceuticals (SUPN) stake by 1.1% in Q2 2026, buying an estimated $4.27K and bringing the position to 8,440 shares worth $393K. The position accounts for 0.01% of the portfolio, ranked #1089.
Maryland State Retirement & Pension System first reported a position in SUPN in Q3 2021 and has held it in 19 quarters since. The position peaked at $789K in Q4 2022. 332 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.
- Maryland State Retirement & Pension System held 8,440 shares of Supernus Pharmaceuticals worth $393K as of Q2 2026.
- Maryland State Retirement & Pension System bought 89 Supernus Pharmaceuticals shares in Q2 2026, an estimated $4.27K.
- Supernus Pharmaceuticals made up 0.01% of Maryland State Retirement & Pension System's portfolio in Q2 2026, its #1089 holding.
- Maryland State Retirement & Pension System first reported a position in Supernus Pharmaceuticals in Q3 2021 and has held it in 19 quarters since.
- Maryland State Retirement & Pension System's Supernus Pharmaceuticals position peaked at $789K in Q4 2022.
- 332 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.
Based on Maryland State Retirement & Pension System's 13F filing for Q2 2026, filed 30 Jul 2026.